Prevention of Organ Allograft Rejection by a Specific Janus Kinase 3 Inhibitor
暂无分享,去创建一个
J. O’Shea | A. Milici | B. Reitz | M. Hines | P. Zagouras | R. Morris | M. Munchhof | M. Saltarelli | D. Ball | T. Woodworth | H. Magna | P. Changelian | T. Blumenkopf | Jeffrey M. Casavant | Jonathan L. Doty | M. Flanagan | Jianmin Sun | D. Whipple | W. Brissette | C. R. Beals | James F. Smith | D. Fisher | M. Conklyn | B. Holm | M. Si | E. Elliott | Matthew F Brown | M. Fisher | J. Moyer | Yong-jie Zhou | D. Borie | Ricardo T. Paniagua | T. Kawabata | W. H. Martin | L. Hayes | D. Finco-Kent | S. McCurdy | B. Littman | T. J. Strelevitz | G. Beckius | E. Kudlacz | J. Higgins | A. Gaweco | Craig R Kent | K. Magnuson | B. Rizzuti | P. Sawyer | B. Perry | E. Koslov | Kwansik Yoon | Brett M. Lillie | C. Subramanyam | Chang Shang-Poa | C. Su | Kimberly S. Johnson | L. Nelms | S. D. Des Etages | Deanna L Baker | Michael J. Larson | Shang-Poa Chang | E. R. Koslov | Chang Shang-Poa
[1] H. Stockinger,et al. Suppression of early T-cell–receptor-triggered cellular activation by the Janus kinase 3 inhibitor WHI-P-154 , 2003, Transplantation.
[2] M. Caligiuri,et al. What does it take to make a natural killer? , 2003, Nature Reviews Immunology.
[3] P. Stock. The Year in Review – ATC 2002 , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[4] A. Sher,et al. A Critical Role for IL-21 in Regulating Immunoglobulin Production , 2002, Science.
[5] R. Fairchild,et al. Chemokines: directing leukocyte infiltration into allografts. , 2002, Current opinion in immunology.
[6] R. Morris,et al. A life-supporting technique of renal allotransplantation in Macaca fascicularis to evaluate novel immunosuppressive drugs in nonhuman primates. , 2002, The Journal of surgical research.
[7] T. Mueller,et al. Analysis of the Innate and Adaptive Phases of Allograft Rejection by Cluster Analysis of Transcriptional Profiles1 , 2002, The Journal of Immunology.
[8] F. Uckun,et al. Janus kinase 3 inhibitor WHI-P131/JANEX-1 prevents graft-versus-host disease but spares the graft-versus-leukemia function of the bone marrow allografts in a murine bone marrow transplantation model. , 2002, Blood.
[9] G. Koretzky,et al. Control of T Cell Function by Positive and Negative Regulators , 2002, Science.
[10] Massimo Gadina,et al. Cytokine Signaling in 2002 New Surprises in the Jak/Stat Pathway , 2002, Cell.
[11] U. Christians,et al. Coadministration of either cyclosporine or steroids with humanized monoclonal antibodies against CD80 and CD86 successfully prolong allograft survival after life supporting renal transplantation in cynomolgus monkeys. , 2001, Transplantation.
[12] R. Kirken,et al. Concomitant Inhibition of Janus Kinase 3 and Calcineurin-Dependent Signaling Pathways Synergistically Prolongs the Survival of Rat Heart Allografts1 , 2001, The Journal of Immunology.
[13] L. Berg,et al. Cutting Edge: Two Distinct Mechanisms Lead to Impaired T Cell Homeostasis in Janus Kinase 3- and CTLA-4-Deficient Mice1 , 2001, The Journal of Immunology.
[14] B. Kahan,et al. Immunosuppressive agents in organ transplantation: past, present, and future. , 2000, Seminars in nephrology.
[15] B. Druker,et al. Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia. , 2000, The Journal of clinical investigation.
[16] H. E. Hansen,et al. The Banff 97 working classification of renal allograft pathology. , 1999, Kidney international.
[17] R. Perlmutter,et al. Requirement for Jak3 in mature T cells: its role in regulation of T cell homeostasis. , 1998, Journal of immunology.
[18] Robert A. Copeland,et al. Enzymes: A Practical Introduction to Structure, Mechanism, and Data Analysis , 1996 .
[19] W. Leonard,et al. Mutation of Jak3 in a Patient with SCID: Essential Role of Jak3 in Lymphoid Development , 1995, Science.
[20] J. Johnston,et al. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID) , 1995, Nature.